Amoxicillin
Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Amoxicillin is a topic covered in the
Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --
INDICATIONS
Treatment of infections due to susceptible (β-lactamase-negative) strains causing the following syndromes:
- Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis.
- Note: empiric use is not recommended by IDSA due to higher rates of resistance to E. coli and poor efficacy[3].
- Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic strains), Staphylococcus spp., or E. coli
- Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to N. gonorrhoeae (males and females). Note: amoxicillin is not recommended by the CDC for the treatment of gonorrhea due to high rates of resistance.
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with other agents.
Amoxicillin ER tablet (Mmoxtag™) is indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatric patients ≥12 y/o
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
Treatment of infections due to susceptible (β-lactamase-negative) strains causing the following syndromes:
- Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis.
- Note: empiric use is not recommended by IDSA due to higher rates of resistance to E. coli and poor efficacy[3].
- Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic strains), Staphylococcus spp., or E. coli
- Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
- Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to N. gonorrhoeae (males and females). Note: amoxicillin is not recommended by the CDC for the treatment of gonorrhea due to high rates of resistance.
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with other agents.
Amoxicillin ER tablet (Mmoxtag™) is indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatric patients ≥12 y/o
There's more to see -- the rest of this entry is available only to subscribers.